Safety and Feasibility of Metformin for Sepsis Induced AKI | MicrobiomeTrials← Back to trialsNCT05900284
Safety and Feasibility of Metformin for Sepsis Induced AKI
CompletedPHASE2INTERVENTIONAL
Trial Details
Start: 2023-11-08Est. Completion: 2026-05-18
Enrollment target: 80 participants Locations- University of Pittsburgh, Pittsburgh, Pennsylvania, United States
Other microbiome trials you might be interested in
Anastomotic LeakColon CancerRight Hemicolectomy
The primary aim of the study is to show that the ileo-colic anastomosis leakage rate until the first 30 days after surge…
Göppingen, GermanyEst. completion Jul 2027
Inflammation IndicesLate Onset Neonatal Sepsis
The diagnosis of late-onset sepsis in term neonates has been studied less than that of early-onset sepsis. Procalcitonin…
Mersin, Turkey (Türkiye)Completed Jul 1, 2024